Multimodal 3D imaging reveals a central role for lysosomes indissolution of cholesterol crystals by…

Abstract

Formation of cholesterol crystals (CCs) is a key event during the development of atherosclerosis, but the molecular mechanisms of their degradation within cells are poorly understood. By incorporating the fluorescent cholesterol analogue TopFluor-Cholesterol (TF-Chol) into CCs, we were able to visualize the uptake of CCs in macrophages using correlative fluorescence and soft X-ray microscopy. Using quantitative 3D live-cell imaging, we show that CCs are processed in late endosomes and lysosomes (LE/Lys), resulting in formation of TF-Chol containing lipid droplets (LDs) over time. Inhibition of lysosomal sterol export with U18666A caused accumulation of TF-Chol in LE/Lys, and inhibition of lysosomal acidification with bafilomycin A1 led to reduced dissolution of the CCs. Using a novel assay combined with 3D image processing, we show that large CCs in contact with macrophages are processed via lysosomal exocytosis followed by extracellular and intracellular degradation of CCs. Treating macrophages with a fluorescent version of cyclodextrin (CD) promoted the dissolution of CCs and enhanced the formation of LDs enriched with TF-Chol. The majority of fluorescent CD co-localized with a marker for LE/Lys during this process, suggesting that intracellular delivery to LE/Lys may contribute to the dissolution of CCs. Dehydroergosterol (DHE) is an intrinsically fluorescent sterol closely mimicking the properties and behavior of cholesterol. DHE is known to self-associate into aggregates and crystals, and by using fluorescence spectroscopy and specialized ultraviolet (UV) microscopy, we found that CD enhances the dissolution of DHE crystals in vitro and in cells. Together, our findings highlight the lysosomal pathway as responsible for dissolution of CCs, cholesterol trafficking, and efflux in macrophages.

TFEB in cardiac stress adaptation: more than just lysosomes
Yohan Santin, Jeanne Mialet-Perez
The Journal of Cardiovascular Aging15 Oct 2026Peer-reviewedCC BYFull textEpidemiology & public healthHAL
Molecular glue degraders of CK1α remodel lysosomes and limit ferroptosis in glioblastoma stem-like cells
J. Jardine, M. Le Guyon, K. Trillet +11
bioRxiv23 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
ClC-7 links PIKfyve inhibition to Rab-dependent LRRK2 activity at lysosomes.
Devin Clegg, Amanda Bentley-DeSousa, Agnes Roczniak-Ferguson +1
The Journal of cell biology20 Oct 2026Peer-reviewedCC BYFull textNeurologyEurope PMC
The Lysosomal Clock: Are We Only as Old as Our Lysosomes?
Alexis Diaz Vegas, Thierry Galli
Traffic (Copenhagen, Denmark)30 Oct 2026Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
Cholesterol-Mediated Modulation of Collecting Lymphatic Vessel Contractility: Exploring Cholesterol Depletion as a Therapeutic Alternative to Improve Lymphatic Function in Hypercholesterolemia
K. Keane, J. A. Castorena-Gonzalez
bioRxiv4 Aug 2026PreprintAll rights reservedFull textPhysiologybioRxiv

Cite

BibTeX RIS

BibTeX

@misc{akkerman2026multimodal,
  title = {{Multimodal 3D imaging reveals a central role for lysosomes indissolution of cholesterol crystals by macrophages}},
  author = {V. Akkerman and A. D. Juhl and J. M. Egebjerg and C. Pratsch and S. Werner and G. Schneider and T. Willms and P. Müller and S. Kapishnikov and D. Wüstner},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.22.753145},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.22.753145v1},
  note = {CC BY-NC-ND},
}

RIS

TY  - UNPB
TI  - Multimodal 3D imaging reveals a central role for lysosomes indissolution of cholesterol crystals by macrophages
AU  - V. Akkerman
AU  - A. D. Juhl
AU  - J. M. Egebjerg
AU  - C. Pratsch
AU  - S. Werner
AU  - G. Schneider
AU  - T. Willms
AU  - P. Müller
AU  - S. Kapishnikov
AU  - D. Wüstner
PY  - 2026
DA  - 2026/09/22
PB  - bioRxiv
DO  - 10.64898/2026.09.22.753145
UR  - https://www.biorxiv.org/content/10.64898/2026.09.22.753145v1
AB  - Formation of cholesterol crystals (CCs) is a key event during the development of atherosclerosis, but the molecular mechanisms of their degradation within cells are poorly understood. By incorporating the fluorescent cholesterol analogue TopFluor-Cholesterol (TF-Chol) into CCs, we were able to visualize the uptake of CCs in macrophages using correlative fluorescence and soft X-ray microscopy. Using quantitative 3D live-cell imaging, we show that CCs are processed in late endosomes and lysosomes (LE/Lys), resulting in formation of TF-Chol containing lipid droplets (LDs) over time. Inhibition of lysosomal sterol export with U18666A caused accumulation of TF-Chol in LE/Lys, and inhibition of lysosomal acidification with bafilomycin A1 led to reduced dissolution of the CCs. Using a novel assay combined with 3D image processing, we show that large CCs in contact with macrophages are processed via lysosomal exocytosis followed by extracellular and intracellular degradation of CCs. Treating macrophages with a fluorescent version of cyclodextrin (CD) promoted the dissolution of CCs and enhanced the formation of LDs enriched with TF-Chol. The majority of fluorescent CD co-localized with a marker for LE/Lys during this process, suggesting that intracellular delivery to LE/Lys may contribute to the dissolution of CCs. Dehydroergosterol (DHE) is an intrinsically fluorescent sterol closely mimicking the properties and behavior of cholesterol. DHE is known to self-associate into aggregates and crystals, and by using fluorescence spectroscopy and specialized ultraviolet (UV) microscopy, we found that CD enhances the dissolution of DHE crystals in vitro and in cells. Together, our findings highlight the lysosomal pathway as responsible for dissolution of CCs, cholesterol trafficking, and efflux in macrophages.
ER  -

Abstract

Related

Cite